Establishment Labs (NASDAQ:ESTA) Sets New 1-Year High – Time to Buy?

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $83.78 and last traded at $83.1170, with a volume of 293524 shares traded. The stock had previously closed at $79.46.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Wall Street Zen lowered shares of Establishment Labs from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research report on Friday, March 27th. Citigroup restated a “neutral” rating on shares of Establishment Labs in a research report on Wednesday, May 6th. Needham & Company LLC lifted their price objective on shares of Establishment Labs from $84.00 to $86.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Finally, BTIG Research boosted their price objective on shares of Establishment Labs from $88.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $87.14.

Establishment Labs Stock Up 7.2%

The company has a current ratio of 2.96, a quick ratio of 1.91 and a debt-to-equity ratio of 16.82. The company has a 50-day simple moving average of $67.77 and a 200 day simple moving average of $68.96. The company has a market cap of $2.51 billion, a P/E ratio of -57.21 and a beta of 1.11.

Establishment Labs (NASDAQ:ESTA) last issued its earnings results on Thursday, May 7th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.10). The company had revenue of $59.88 million for the quarter, compared to analysts’ expectations of $57.40 million. Establishment Labs had a negative net margin of 19.05% and a negative return on equity of 218.77%. The firm’s revenue for the quarter was up 44.7% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.70) earnings per share. On average, equities analysts anticipate that Establishment Labs Holdings Inc. will post -1.07 EPS for the current year.

Insider Buying and Selling

In other news, Director Quiros Juan Jose Chacon sold 105,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 6th. The shares were sold at an average price of $75.42, for a total transaction of $7,919,100.00. Following the transaction, the director directly owned 927,504 shares of the company’s stock, valued at approximately $69,952,351.68. This trade represents a 10.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In the last 90 days, insiders have sold 330,000 shares of company stock valued at $22,854,538. 9.99% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ESTA. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Establishment Labs by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 57,215 shares of the company’s stock worth $2,335,000 after buying an additional 9,557 shares during the period. Geode Capital Management LLC raised its holdings in shares of Establishment Labs by 1.2% in the second quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock valued at $1,105,000 after acquiring an additional 299 shares in the last quarter. WINTON GROUP Ltd bought a new stake in shares of Establishment Labs in the second quarter valued at about $651,000. Nebula Research & Development LLC lifted its stake in Establishment Labs by 27.9% in the second quarter. Nebula Research & Development LLC now owns 16,214 shares of the company’s stock worth $692,000 after acquiring an additional 3,538 shares during the period. Finally, Sei Investments Co. grew its holdings in Establishment Labs by 13.3% during the 2nd quarter. Sei Investments Co. now owns 48,428 shares of the company’s stock worth $2,068,000 after acquiring an additional 5,668 shares in the last quarter. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.